These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10856732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors.
    Gremmler B, Kisters K, Kunert M, Schleiting H, Ulbricht LJ.
    Acta Cardiol; 2007 Aug; 62(4):321-8. PubMed ID: 17824291
    [Abstract] [Full Text] [Related]

  • 3. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR, McDonagh TA, Farmer R, Morton JJ, McMurray JJ, Dargie HJ.
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of hypertension: the advent of a new angiotensin II receptor antagonist.
    Hedner T.
    J Hypertens Suppl; 1999 Jun; 17(2):S21-5. PubMed ID: 10465063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The clinical profile of the angiotensin II receptor blocker eprosartan.
    Hedner T.
    J Hypertens Suppl; 2002 Jun; 20(5):S33-8. PubMed ID: 12184062
    [Abstract] [Full Text] [Related]

  • 12. Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.
    Suzuki G, Mishima T, Tanhehco EJ, Sharov VG, Todor A, Rostogi S, Gupta RC, Chaudhry PA, Anagnostopoulos PV, Nass O, Goldstein S, Sabbah HN.
    Br J Pharmacol; 2003 Jan; 138(2):301-9. PubMed ID: 12540520
    [Abstract] [Full Text] [Related]

  • 13. Clinical profile of eprosartan.
    Puig JG, López MA, Bueso TS, Bernardino JI, Jiménez RT, Grupo MAPA-MADRID Investigators.
    Cardiovasc Drugs Ther; 2002 Dec; 16(6):543-9. PubMed ID: 12766389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.